1
KRYSTAL BIOTECH INC
COM
KRYS
KRYS
939,254
$349.1m12.03%
12.03%
Reduced Shares held: Q3 2025 1.0m, Q4 2025 941.1k, Q1 2026 1.2m, Q2 2026 939.3k
-213.8k
-213,833
-18.5%
2
CELCUITY INC
COM
CELC
CELC
1,704,318
$178.3m6.14%
6.14%
Added Shares held: Q3 2025 1.2m, Q4 2025 1.8m, Q1 2026 1.3m, Q2 2026 1.7m
+419.9k
+419,940
32.7%
3
TG THERAPEUTICS INC
COM
TGTX
TGTX
2,927,895
$160.9m5.54%
5.54%
Reduced Shares held: Q3 2025 3.8m, Q4 2025 3.1m, Q1 2026 4.0m, Q2 2026 2.9m
-1.1m
-1,101,424
-27.3%
4
INSULET CORP
COM
PODD
PODD
1,049,000
$159.7m5.50%
5.50%
Added Shares held: Q3 2025 0, Q4 2025 150.0k, Q1 2026 562.5k, Q2 2026 1.0m
+486.5k
+486,500
86.5%
5
NOVOCURE LTD
ORD SHS
NVCR
NVCR
9,913,401
$150.2m5.18%
5.18%
Reduced Shares held: Q3 2025 9.6m, Q4 2025 8.5m, Q1 2026 10.5m, Q2 2026 9.9m
-579.0k
-578,990
-5.5%
6
UNITED THERAPEUTICS CORP DEL
COM
UTHR
UTHR
225,587
$122.2m4.21%
4.21%
Added Shares held: Q3 2025 150.0k, Q4 2025 60.0k, Q1 2026 187.2k, Q2 2026 225.6k
+38.4k
+38,400
20.5%
7
INSPIRE MED SYS INC
COM
INSP
INSP
1,931,436
$86.2m2.97%
2.97%
Added Shares held: Q3 2025 728.2k, Q4 2025 299.4k, Q1 2026 576.3k, Q2 2026 1.9m
+1.4m
+1,355,137
235.1%
8
RIGEL PHARMACEUTICALS INC
COM
RIGL
RIGL
1,843,504
$72.1m2.49%
2.49%
Added Shares held: Q3 2025 330.0k, Q4 2025 300.0k, Q1 2026 10.0k, Q2 2026 1.8m
+1.8m
+1,833,504
18335.0%
9
ANI PHARMACEUTICALS INC
COM
ANIP
ANIP
867,760
$71.8m2.48%
2.48%
Added Shares held: Q3 2025 340.2k, Q4 2025 486.2k, Q1 2026 820.2k, Q2 2026 867.8k
+47.5k
+47,517
5.8%
10
BETA BIONICS INC
COM
BBNX
BBNX
4,393,714
$68.8m2.37%
2.37%
Added Shares held: Q3 2025 3.9m, Q4 2025 2.5m, Q1 2026 4.4m, Q2 2026 4.4m
+39.2k
+39,213
0.9%
11
VERICEL CORP
COM
VCEL
VCEL
1,459,152
$64.9m2.24%
2.24%
Reduced Shares held: Q3 2025 498.0k, Q4 2025 764.0k, Q1 2026 2.5m, Q2 2026 1.5m
-1.1m
-1,089,927
-42.8%
12
PRAXIS PRECISION MEDICINES I
COM NEW
PRAX
PRAX
177,517
$59.4m2.05%
2.05%
Reduced Shares held: Q3 2025 859.2k, Q4 2025 363.0k, Q1 2026 330.5k, Q2 2026 177.5k
-153.0k
-153,000
-46.3%
13
GERON CORP
COM
GERN
GERN
42,808,659
$54.8m1.89%
1.89%
Added Shares held: Q3 2025 17.3m, Q4 2025 23.3m, Q1 2026 41.5m, Q2 2026 42.8m
+1.3m
+1,300,000
3.1%
14
ALKERMES PLC
SHS
ALKS
ALKS
1,029,252
$53.9m1.86%
1.86%
Reduced Shares held: Q3 2025 0, Q4 2025 1.3m, Q1 2026 2.0m, Q2 2026 1.0m
-941.6k
-941,612
-47.8%
15
ERASCA INC
COM
ERAS
ERAS
2,700,000
$49.5m1.70%
1.70%
New Shares held: Q3 2025 2.2m, Q4 2025 2.2m, Q1 2026 0, Q2 2026 2.7m
16
NEUROPACE INC
COM
NPCE
NPCE
2,911,122
$46.3m1.59%
1.59%
Reduced Shares held: Q3 2025 3.0m, Q4 2025 2.7m, Q1 2026 2.9m, Q2 2026 2.9m
-21.1k
-21,085
-0.7%
17
PROGYNY INC
COM
PGNY
PGNY
1,602,000
$46.2m1.59%
1.59%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.1m, Q2 2026 1.6m
-465.0k
-465,000
-22.5%
18
INDIVIOR PHARMACEUTICALS INC
COM
INDV
INDV
1,064,000
$43.7m1.50%
1.50%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.3m, Q2 2026 1.1m
-210.0k
-210,000
-16.5%
19
PARABILIS MEDICINES INC
COM
PBLS
PBLS
1,465,070
$40.1m1.38%
1.38%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.5m
20
EDAP TMS S A
SPONSORED ADR
FOCL
FOCL
7,309,254
$37.9m1.30%
1.30%
Unchanged Shares held: Q3 2025 7.3m, Q4 2025 7.3m, Q1 2026 7.3m, Q2 2026 7.3m
21
GLOBUS MED INC
CL A
GMED
GMED
468,922
$37.0m1.28%
1.28%
Reduced Shares held: Q3 2025 176.0k, Q4 2025 887.0k, Q1 2026 729.5k, Q2 2026 468.9k
-260.5k
-260,545
-35.7%
22
ARCUS BIOSCIENCES INC
COM
RCUS
RCUS
1,168,738
$36.0m1.24%
1.24%
Added Shares held: Q3 2025 0, Q4 2025 712.0k, Q1 2026 452.0k, Q2 2026 1.2m
+716.8k
+716,755
158.6%
23
SYNDAX PHARMACEUTICALS INC
COM
SNDX
SNDX
1,628,039
$35.6m1.23%
1.23%
Reduced Shares held: Q3 2025 2.0m, Q4 2025 2.2m, Q1 2026 1.7m, Q2 2026 1.6m
-98.9k
-98,869
-5.7%
24
NURIX THERAPEUTICS INC
COM
NRIX
NRIX
1,465,163
$35.5m1.22%
1.22%
Added Shares held: Q3 2025 2.4m, Q4 2025 1.2m, Q1 2026 938.2k, Q2 2026 1.5m
+527.0k
+527,000
56.2%
25
LEGEND BIOTECH CORP
SPONSORED ADS
LEGN
LEGN
1,205,000
$34.8m1.20%
1.20%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.2m
26
JADE BIOSCIENCES INC
COM NEW
JBIO
JBIO
1,550,690
$34.5m1.19%
1.19%
Added Shares held: Q3 2025 796.7k, Q4 2025 796.7k, Q1 2026 796.7k, Q2 2026 1.6m
+753.9k
+753,946
94.6%
27
UNITEDHEALTH GROUP INC
COM
UNH
UNH
80,000
$33.3m1.15%
1.15%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 80.0k
28
AVALO THERAPEUTICS INC
COM NEW
AVTX
AVTX
1,654,978
$30.6m1.05%
1.05%
Added Shares held: Q3 2025 0, Q4 2025 442.0k, Q1 2026 442.0k, Q2 2026 1.7m
+1.2m
+1,213,000
274.4%
29
UROGEN PHARMA LTD
COM
URGN
URGN
829,810
$30.5m1.05%
1.05%
Added Shares held: Q3 2025 679.0k, Q4 2025 150.0k, Q1 2026 727.0k, Q2 2026 829.8k
+102.8k
+102,810
14.1%
30
MBX BIOSCIENCES INC
COM
MBX
MBX
515,279
$28.4m0.98%
0.98%
Added Shares held: Q3 2025 275.0k, Q4 2025 408.9k, Q1 2026 178.9k, Q2 2026 515.3k
+336.4k
+336,382
188.0%
31
PALISADE BIO INC
COM
PALI
PALI
13,063,687
$27.3m0.94%
0.94%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 13.1m
32
PHARVARIS N V
COM
PHVS
PHVS
730,907
$25.3m0.87%
0.87%
Added Shares held: Q3 2025 647.1k, Q4 2025 702.1k, Q1 2026 702.1k, Q2 2026 730.9k
+28.9k
+28,855
4.1%
33
ORGANOGENESIS HLDGS INC
COM
ORGO
ORGO
10,140,951
$24.6m0.85%
0.85%
Added Shares held: Q3 2025 12.1m, Q4 2025 10.0m, Q1 2026 10.1m, Q2 2026 10.1m
+55.0k
+55,000
0.6%
34
SUPERNUS PHARMACEUTICALS INC
COM
SUPN
SUPN
520,000
$24.2m0.83%
0.83%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 520.0k
35
PROCEPT BIOROBOTICS CORP
COM
PRCT
PRCT
1,003,000
$22.6m0.78%
0.78%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 160.0k, Q2 2026 1.0m
+843.0k
+843,000
526.9%
36
TANGO THERAPEUTICS INC
COM
TNGX
TNGX
709,000
$22.2m0.76%
0.76%
Added Shares held: Q3 2025 300.0k, Q4 2025 10.0k, Q1 2026 450.0k, Q2 2026 709.0k
+259.0k
+259,000
57.6%
37
INHIBIKASE THERAPEUTICS INC
COM NEW
IKT
IKT
10,875,000
$22.1m0.76%
0.76%
Unchanged Shares held: Q3 2025 6.3m, Q4 2025 10.9m, Q1 2026 10.9m, Q2 2026 10.9m
38
TREVI THERAPEUTICS INC
COM
TRVI
TRVI
1,179,618
$22.0m0.76%
0.76%
Reduced Shares held: Q3 2025 25.0k, Q4 2025 900.0k, Q1 2026 1.6m, Q2 2026 1.2m
-440.4k
-440,382
-27.2%
39
BIOMARIN PHARMACEUTICAL INC
COM
BMRN
BMRN
375,572
$21.5m0.74%
0.74%
Reduced Shares held: Q3 2025 890.3k, Q4 2025 1.3m, Q1 2026 650.6k, Q2 2026 375.6k
-275.0k
-275,000
-42.3%
40
LIVANOVA PLC
SHS
LIVN
LIVN
254,957
$21.0m0.72%
0.72%
Reduced Shares held: Q3 2025 0, Q4 2025 567.5k, Q1 2026 582.5k, Q2 2026 255.0k
-327.5k
-327,543
-56.2%
41
ARGENX SE
SPONSORED ADR
ARGX
ARGX
19,955
$18.5m0.64%
0.64%
Added Shares held: Q3 2025 69.4k, Q4 2025 31.7k, Q1 2026 3.5k, Q2 2026 20.0k
+16.5k
+16,455
470.1%
42
NUVECTIS PHARMA INC
COM
NVCT
NVCT
1,000,000
$18.4m0.63%
0.63%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.0m
43
CAPRICOR THERAPEUTICS INC
COM NEW
CAPR
CAPR
761,737
$18.3m0.63%
0.63%
New Shares held: Q3 2025 0, Q4 2025 646.4k, Q1 2026 0, Q2 2026 761.7k
44
EDGEWISE THERAPEUTICS INC
COM
EWTX
EWTX
450,889
$18.3m0.63%
0.63%
Reduced Shares held: Q3 2025 0, Q4 2025 910.0k, Q1 2026 1.4m, Q2 2026 450.9k
-999.0k
-999,026
-68.9%
45
PRELUDE THERAPEUTICS INC
COM
PRLD
PRLD
3,378,378
$18.0m0.62%
0.62%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.4m
46
XENON PHARMACEUTICALS INC
COM
XENE
XENE
267,000
$16.1m0.56%
0.56%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 292.0k, Q2 2026 267.0k
-25.0k
-25,000
-8.6%
47
C4 THERAPEUTICS INC
COM STK
CCCC
CCCC
3,377,981
$15.8m0.54%
0.54%
Reduced Shares held: Q3 2025 7.1m, Q4 2025 3.8m, Q1 2026 3.8m, Q2 2026 3.4m
-426.0k
-425,961
-11.2%
48
KINIKSA PHARMACEUTICALS INTL
ORD SHS CL A
KNSA
KNSA
246,353
$15.8m0.54%
0.54%
Reduced Shares held: Q3 2025 150.0k, Q4 2025 587.0k, Q1 2026 521.4k, Q2 2026 246.4k
-275.0k
-275,000
-52.8%
49
ORTHOPEDIATRICS CORP
COM
KIDS
KIDS
732,144
$14.0m0.48%
0.48%
Added Shares held: Q3 2025 128.0k, Q4 2025 525.4k, Q1 2026 615.4k, Q2 2026 732.1k
+116.7k
+116,697
19.0%
50
AVALYN PHARMACEUTICALS INC
COM SHS
AVLN
AVLN
419,000
$13.8m0.48%
0.48%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 419.0k
51
BIODESIX INC
COM
BDSX
BDSX
585,958
$13.2m0.46%
0.46%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 416.6k, Q2 2026 586.0k
+169.4k
+169,359
40.6%
52
SPYRE THERAPEUTICS INC
COM NEW
SYRE
SYRE
147,000
$13.1m0.45%
0.45%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 147.0k
53
TWIST BIOSCIENCE CORP
COM
TWST
TWST
104,629
$10.8m0.37%
0.37%
Reduced Shares held: Q3 2025 1.9m, Q4 2025 1.9m, Q1 2026 1.2m, Q2 2026 104.6k
-1.1m
-1,122,000
-91.5%
54
VIR BIOTECHNOLOGY INC
COM
VIR
VIR
1,000,000
$10.2m0.35%
0.35%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.0m, Q2 2026 1.0m
-1.0m
-1,002,000
-50.0%
55
ALNYLAM PHARMACEUTICALS INC
COM
ALNY
ALNY
33,050
$9.9m0.34%
0.34%
Reduced Shares held: Q3 2025 15.2k, Q4 2025 70.0k, Q1 2026 131.7k, Q2 2026 33.0k
-98.6k
-98,600
-74.9%
56
IMMUNOVANT INC
COM
IMVT
IMVT
252,000
$9.7m0.33%
0.33%
Added Shares held: Q3 2025 0, Q4 2025 1.1m, Q1 2026 230.0k, Q2 2026 252.0k
+22.0k
+22,000
9.6%
57
INSMED INC
COM PAR $.01
INSM
INSM
90,250
$9.6m0.33%
0.33%
Added Shares held: Q3 2025 2.5k, Q4 2025 48.5k, Q1 2026 10.2k, Q2 2026 90.2k
+80.0k
+80,000
780.5%
58
SEPTERNA INC
COM
SEPN
SEPN
275,000
$9.2m0.32%
0.32%
Unchanged Shares held: Q3 2025 18.3k, Q4 2025 383.4k, Q1 2026 275.0k, Q2 2026 275.0k
59
SOPHIA GENETICS SA
ORDINARY SHARES
SOPH
SOPH
1,565,000
$9.0m0.31%
0.31%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.9m, Q2 2026 1.6m
-285.0k
-285,000
-15.4%
60
NEKTAR THERAPEUTICS
COM NEW
NKTR
NKTR
128,362
$9.0m0.31%
0.31%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 128.4k
61
MIRUM PHARMACEUTICALS INC
COM
MIRM
MIRM
75,000
$8.8m0.30%
0.30%
Reduced Shares held: Q3 2025 148.7k, Q4 2025 573.6k, Q1 2026 400.3k, Q2 2026 75.0k
-325.3k
-325,306
-81.3%
62
ARTIVION INC
COM
AORT
AORT
388,000
$8.7m0.30%
0.30%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 388.0k
63
TANDEM DIABETES CARE INC
COM NEW
TNDM
TNDM
575,000
$8.7m0.30%
0.30%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 783.0k, Q2 2026 575.0k
-208.0k
-208,000
-26.6%
64
ENLIVEN THERAPEUTICS INC
COM
ELVN
ELVN
165,677
$8.4m0.29%
0.29%
Reduced Shares held: Q3 2025 0, Q4 2025 1.0m, Q1 2026 230.9k, Q2 2026 165.7k
-65.2k
-65,192
-28.2%
65
SIONNA THERAPEUTICS INC
COM
SION
SION
177,687
$7.8m0.27%
0.27%
Reduced Shares held: Q3 2025 413.5k, Q4 2025 268.5k, Q1 2026 293.5k, Q2 2026 177.7k
-115.8k
-115,813
-39.5%
66
BELITE BIO INC
SPONSORED ADS
BLTE
BLTE
50,524
$7.8m0.27%
0.27%
New Shares held: Q3 2025 210.0k, Q4 2025 40.4k, Q1 2026 0, Q2 2026 50.5k
67
CERUS CORP
COM
CERS
CERS
2,500,000
$7.3m0.25%
0.25%
Reduced Shares held: Q3 2025 0, Q4 2025 4.0m, Q1 2026 10.8m, Q2 2026 2.5m
-8.3m
-8,253,700
-76.8%
68
SILENCE THERAPEUTICS PLC
ADS
SLN
SLN
630,000
$6.9m0.24%
0.24%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 630.0k
69
IMMUNIC INC
COM NEW
IMUX
IMUX
450,000
$6.9m0.24%
0.24%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 450.0k
70
INVIVYD INC
COM
IVVD
IVVD
7,708,727
$6.7m0.23%
0.23%
Unchanged Shares held: Q3 2025 0, Q4 2025 7.7m, Q1 2026 7.7m, Q2 2026 7.7m
71
MERCK & CO INC
COM
MRK
MRK
50,000
$6.4m0.22%
0.22%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 203.0k, Q2 2026 50.0k
-153.0k
-153,000
-75.4%
72
RELMADA THERAPEUTICS INC
COM
RLMD
RLMD
842,106
$5.8m0.20%
0.20%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 842.1k, Q2 2026 842.1k
73
STRUCTURE THERAPEUTICS INC
SPONSORED ADS
GPCR
GPCR
107,000
$5.7m0.20%
0.20%
Added Shares held: Q3 2025 0, Q4 2025 90.0k, Q1 2026 80.0k, Q2 2026 107.0k
+27.0k
+27,000
33.8%
74
EVOLUS INC
COM
EOLS
EOLS
822,428
$5.7m0.20%
0.20%
Reduced Shares held: Q3 2025 1.4m, Q4 2025 1.1m, Q1 2026 2.2m, Q2 2026 822.4k
-1.4m
-1,422,932
-63.4%
75
ADLAI NORTYE LTD
SPONSORED ADS
ANL
ANL
405,523
$4.7m0.16%
0.16%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 405.5k
76
ZENTALIS PHARMACEUTICALS INC
COM
ZNTL
ZNTL
950,000
$4.6m0.16%
0.16%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 950.0k
77
KARYOPHARM THERAPEUTICS INC
COM NEW
KPTI
KPTI
440,000
$4.3m0.15%
0.15%
Unchanged Shares held: Q3 2025 0, Q4 2025 440.0k, Q1 2026 440.0k, Q2 2026 440.0k
78
CONTEXT THERAPEUTICS INC
COM
CNTX
CNTX
7,063,141
$3.9m0.13%
0.13%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 7.0m, Q2 2026 7.1m
+100.0k
+100,000
1.4%
79
PULMONX CORP
COM
LUNG
LUNG
2,788,323
$3.6m0.12%
0.12%
Unchanged Shares held: Q3 2025 0, Q4 2025 2.0m, Q1 2026 2.8m, Q2 2026 2.8m
80
SAB BIOTHERAPEUTICS INC
COM NEW
SABS
SABS
900,000
$3.5m0.12%
0.12%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.1m, Q2 2026 900.0k
-150.0k
-150,000
-14.3%
81
TECTONIC THERAPEUTIC INC
COM
TECX
TECX
101,684
$3.5m0.12%
0.12%
Reduced Shares held: Q3 2025 25.0k, Q4 2025 0, Q1 2026 121.7k, Q2 2026 101.7k
-20.0k
-20,000
-16.4%
82
AXOGEN INC
COM
AXGN
AXGN
57,036
$2.6m0.09%
0.09%
Reduced Shares held: Q3 2025 1.7m, Q4 2025 1.2m, Q1 2026 679.2k, Q2 2026 57.0k
-622.1k
-622,134
-91.6%
83
SATELLOS BIOSCIENCE INC
COM
MSLE
MSLE
314,359
$2.4m0.08%
0.08%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 414.4k, Q2 2026 314.4k
-100.0k
-100,000
-24.1%
84
ARRIVENT BIOPHARMA INC
COM
AVBP
AVBP
50,000
$1.7m0.06%
0.06%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 50.0k
85
CORCEPT THERAPEUTICS INC
COM
CORT
CORT
19,653
$1.7m0.06%
0.06%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 285.5k, Q2 2026 19.7k
-265.9k
-265,878
-93.1%
86
SOLID BIOSCIENCES INC
COM NEW
SLDB
SLDB
150,000
$1.5m0.05%
0.05%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 150.0k
87
VERACYTE INC
COM
VCYT
VCYT
25,000
$1.5m0.05%
0.05%
Reduced Shares held: Q3 2025 422.1k, Q4 2025 10.0k, Q1 2026 319.9k, Q2 2026 25.0k
-294.9k
-294,912
-92.2%
88
CULLINAN THERAPEUTICS INC
COM
CGEM
CGEM
50,000
$910.5k0.03%
0.03%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 410.2k, Q2 2026 50.0k
-360.2k
-360,200
-87.8%
89
INSPIREMD INC
COM
NSPR
NSPR
1,045,708
$732.1k0.03%
0.03%
Unchanged Shares held: Q3 2025 1.5m, Q4 2025 1.1m, Q1 2026 1.0m, Q2 2026 1.0m
90
GENEDX HOLDINGS CORP
COM CL A
WGS
WGS
10,000
$686.5k0.02%
0.02%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 10.0k
91
IOVANCE BIOTHERAPEUTICS INC
COM
IOVA
IOVA
150,000
$624.0k0.02%
0.02%
Reduced Shares held: Q3 2025 976.7k, Q4 2025 0, Q1 2026 1.0m, Q2 2026 150.0k
-850.0k
-850,000
-85.0%
92
LARIMAR THERAPEUTICS INC
COM
LRMR
LRMR
188,102
$573.7k0.02%
0.02%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.1m, Q2 2026 188.1k
-878.9k
-878,858
-82.4%
93
CG ONCOLOGY INC
COM
CGON
CGON
5,000
$355.2k0.01%
0.01%
Reduced Shares held: Q3 2025 290.0k, Q4 2025 170.0k, Q1 2026 20.0k, Q2 2026 5.0k
-15.0k
-15,000
-75.0%
94
QUOIN PHARMACEUTICALS LTD
SPONSORED ADS
QNRX
QNRX
72,730
$352.0k0.01%
0.01%
Unchanged Shares held: Q3 2025 0, Q4 2025 25.0k, Q1 2026 72.7k, Q2 2026 72.7k
95
EQUILLIUM INC
COM
EQ
EQ
90,000
$288.0k0.01%
0.01%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 90.0k
96
NATERA INC
COM
NTRA
NTRA
1,000
$271.4k0.01%
0.01%
Reduced Shares held: Q3 2025 0, Q4 2025 20.0k, Q1 2026 119.0k, Q2 2026 1.0k
-118.0k
-118,000
-99.2%
97
NEOGENOMICS INC
COM NEW
NEO
NEO
10,000
$145.9k0.01%
0.01%
Reduced Shares held: Q3 2025 0, Q4 2025 427.5k, Q1 2026 175.0k, Q2 2026 10.0k
-165.0k
-165,000
-94.3%